APA (7th ed.) Citation

Fernández-Navarro, P., López-Nieva, P., Piñeiro-Yañez, E., Carreño-Tarragona, G., Martinez-López, J., Sánchez Pérez, R., . . . Fernández-Piqueras, J. (2019). The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data. BMC Cancer, 19(1), . https://doi.org/10.1186/s12885-019-6209-9

Chicago Style (17th ed.) Citation

Fernández-Navarro, Pablo, et al. "The Use of PanDrugs to Prioritize Anticancer Drug Treatments in a Case of T-ALL Based on Individual Genomic Data." BMC Cancer 19, no. 1 (2019). https://doi.org/10.1186/s12885-019-6209-9.

MLA (9th ed.) Citation

Fernández-Navarro, Pablo, et al. "The Use of PanDrugs to Prioritize Anticancer Drug Treatments in a Case of T-ALL Based on Individual Genomic Data." BMC Cancer, vol. 19, no. 1, 2019, https://doi.org/10.1186/s12885-019-6209-9.